BAP1
5 abstracts
Abstract
Association of somatic mutations and histologic subtype/grade on prognosis and PD-L1 expression in mesothelioma.Org: University of Chicago, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA, University of Chicago Bucksbaum Institute for Clinical Excellence, Section of Hematology/Oncology, The University of Chicago Medicine,
Abstract
Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.Org: Memorial Sloan Kettering Cancer Center, Weill Cornell College of Medicine, Weill Medical College,
Abstract
Blood-based molecular profiling of Chinese patients with advanced renal cell carcinoma.Org: Department of Urology, Jinling Hospital, Clinical School of Medical College, Nanjing University, Nanjing, China, Ningbo Urology & Nephrology Hospital, AcornMed Biotechnology Co., Ltd., Beijing, China,
Abstract
Investigation of the prognostic significance of CD5, CD117, EZH2, POU2F3, MTAP and BAP1 in thymic carcinoma.Org: Mayo Clinic, Department of Laboratory Medicine and Pathology, University of Washington, Department of Radiation Oncology, Sichuan Cancer Hospital & Institute, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China, Division of Thoracic Surgery, Brigham and Women's Hospital, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, SongDang Institute for Cancer Research, Yonsei University College of Medicine, Seoul, South Korea,
Abstract
Genome sequencing-based prognosis, mutational analysis, and survival rate of clear cell renal cell carcinoma.Org: University of Santo Tomas Faculty of Medicine and Surgery, Manila, Philippines, Tianjin University of Chinese Medicine, Tianjin, China, Montefiore Medical Center, Bronx, NY, Batterjee Medical College, Jeddah, Saudi Arabia, Houston Methodist Hospital, Houston, TX,